WESCO and Anixter merger still on track, despite Covid-19 impact

PITTSBURGH — WESCO International Inc. (NYSE: WCC) joined the list of Pittsburgh based companies withdrawing financial guidance due to the uncertainty around the Covid-19 pandemic, but the company’s leadership sees its recent merger with Anixter International as a benefit, according to a news release.

“With the challenging economic cycle we’re facing near term, this strategic combination remains compelling as we’re doubling the size of our company and will transform the new enterprise through execution of the integration plan and delivery of the synergies,” WESCO President and CEO John Engel said in a prepared statement.

Engel said in the release that integration actions continue to accelerate between WESCO and Anixter, and he said the parties are still on track to close the transaction in the second or third quarter of this year.

Click here to read more from the Pittsburgh Business Times.

Pittsburgh company’s COVID-19 treatment headed for clinical trial Pittsburgh company’s COVID-19 treatment headed for clinical trial

© 2020 Cox Media Group